ResMed will plunk down $225 million to acquire Propeller Health, marking the San Diego company’s third acquisition announcement this year.
Connect honored seven companies with its "Most Innovative Product" award on Nov. 30.
San Diego’s Dexcom will pay $250 million in stock to Verily — a subsidiary of Google parent company Alphabet — as part of an amended deal. One analyst called the revision a financial and strategic win for Dexcom.
Sharp Healthcare has found a CEO to succeed Mike Murphy, who announced his retirement in April.
ViaCyte recently hauled in an $80 million Series D round to advance therapies that the company called a potential “functional cure” for Type 1 diabetes patients.
A respiratory test from San Diego-based Mesa Biotech recently received U.S. Food and Drug Administration clearance and a key waiver.
San Diego-based Jecure Therapeutics and its inflammatory disease platform has been snapped up by Genentech, it was announced Nov. 27.
Arena Pharmaceuticals on Nov. 15 announced a drug licensing deal that provides the company with ample cash to devote to other medicines in its pipeline.
Biomatrica — started in 2005 by husband-and-wife scientists who invented a preservative for keeping DNA and other biological samples at room temperature — was acquired last month by Exact Sciences Corp.
In 2014, pharmaceutical Shire bought San Diego company Lumena and its lead drug candidate, called maralixibat. Now maralixibat is back in the hands of former Lumena talent.
A team of Salk Institute researchers has been awarded $19.2 million to study interactions among brain systems thought to underlie disorders like Alzheimer’s disease. Sparking new therapies is another goal.
High demand for biotech startup space convinced BioLabs San Diego to open a second facility in the UTC area of San Diego.
San Diego’s Dexcom will pay $250 million in stock to Verily – a subsidiary of Google parent company Alphabet – as part an amended deal.
Home sales were up ever-so-slightly in October in San Diego County compared with September but still lag far behind where they were a year ago, according to the Greater San Diego Association of Realtors.
Change is blowing through DJO Global, after the medical device company announced plans this summer to relocate from San Diego to Texas. Then came news on Nov. 19 that DJO was acquired for $3.15 billion.